| The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma (NCT05144087) | University Hospital Southampton NHS Foundation Trust | 2022-05-25 |
| Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI (NCT03733535) | Dr. Grace Parraga | 2022-03-01 |
| The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma (NCT05241769) | University Hospital Birmingham | 2022-03-01 |
| Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma (NCT05091385) | Medical University of Lodz | 2022-01-01 |
| Predictive Signature of Benralizumab Response (NCT04565483) | Nantes University Hospital | 2021-10-11 |
| Interaction Between Benralizumab and Basophils in Eosinophilic Asthma (NCT04742504) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2021-09-07 |
| Evaluation of Volatile Organic Compounds in Mepolizumab Therapy (NCT04924478) | University Hospital Southampton NHS Foundation Trust | 2021-07-01 |
| Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma (NCT04710134) | McMaster University | 2021-02-10 |
| Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO) (NCT04612556) | Aristotle University Of Thessaloniki | 2021-01-22 |
| Patients With Severe Eosinophilic Asthma Treated With Benralizumab (NCT05078281) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2020-11-01 |
| Asthma Control in a Dutch Primary Care Population (NCT04456270) | General Practitioners Research Institute | 2020-10-01 |
| Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma (NCT04512521) | Hannover Medical School | 2020-05-04 |
| Anti-viral Effects of Azithromycin in Patients With Asthma and COPD (NCT04319705) | Bispebjerg Hospital | 2020-03-02 |
| Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients (NCT04181190) | Università degli Studi di Ferrara | 2019-10-11 |
| Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma (NCT04049175) | Chiesi Farmaceutici S.p.A. | 2019-08-28 |
| Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma (NCT03453021) | University Hospital, Grenoble | 2016-01-25 |